Risk factors of Pancreatic Cancer in Vietnam: A Matched Case-Control Hospital-Based Study
- PMID: 33517745
- PMCID: PMC8482704
- DOI: 10.1177/1073274821989320
Risk factors of Pancreatic Cancer in Vietnam: A Matched Case-Control Hospital-Based Study
Abstract
Background: Data about the risk factors and pancreatic cancer in developing countries remain limited. We investigated for the first time the role of a number of risk factors (family cancer history, smoking, alcohol consumption, diabetes, inflammation disease, HBV infection) associated with pancreatic cancer among Vietnamese patients.
Methods: We included all patients hospitalized at 4 Northern Vietnamese hospitals (Vietnam National Cancer Hospital, Bach Mai, Viet Duc, Thai Nguyen) and diagnosed with pancreatic cancer during the period from 2017 to 2019. Risk factors of eligible patients were collected and assessed the associations using a matched control study and logistic regression model analysis.
Results: We identified 196 patients with diagnosis of pancreatic cancer of which 114 males and 82 females. The average age of the patient at the time of diagnosis was 58.28 years (standard deviation of 12.94, ranging from 25 to 87). Most of patients were diagnosed at advanced stage (85%). Smoking, diabetes, inflammation disease significantly increased the cancer risks (OR and 95% CI were 2.42 (1.38-4.37), 3.09 (1.54-6.68), 2.21 (1.42-3.45), respectively). HBV infection demonstrated a significant link with pancreatic cancer in univariate model (OR = 2.94 (1.08-9.36)), but not in multivariate model. However, cancer family history and alcohol drinkers did not show any significantly increased risk related to pancreatic cancer.
Conclusions: Our finding showed smoking, diabetes, inflammation disease significantly increased the risk of pancreatic cancer in Vietnam.
Keywords: Vietnam; diabetes; pancreatic cancer; risk factors; smoking.
Conflict of interest statement
Similar articles
-
Risk factors for pancreatic cancer: case-control study.Am J Gastroenterol. 2007 Dec;102(12):2696-707. doi: 10.1111/j.1572-0241.2007.01510.x. Epub 2007 Aug 31. Am J Gastroenterol. 2007. PMID: 17764494 Free PMC article.
-
Risk factors for pancreatic cancer: a case-control study based on direct interviews.Teratog Carcinog Mutagen. 2001;21(1):7-25. doi: 10.1002/1520-6866(2001)21:1<7::aid-tcm3>3.0.co;2-a. Teratog Carcinog Mutagen. 2001. PMID: 11135318
-
Tobacco smoking, alcohol consumption and pancreatic cancer risk: a case-control study in Italy.Eur J Cancer. 2010 Jan;46(2):370-6. doi: 10.1016/j.ejca.2009.09.002. Epub 2009 Sep 24. Eur J Cancer. 2010. PMID: 19782561
-
Tobacco and alcohol as risk factors for pancreatic cancer.Best Pract Res Clin Gastroenterol. 2017 Oct;31(5):529-536. doi: 10.1016/j.bpg.2017.09.001. Epub 2017 Sep 6. Best Pract Res Clin Gastroenterol. 2017. PMID: 29195672 Free PMC article. Review.
-
Alcohol consumption on pancreatic diseases.World J Gastroenterol. 2013 Feb 7;19(5):638-47. doi: 10.3748/wjg.v19.i5.638. World J Gastroenterol. 2013. PMID: 23429423 Free PMC article. Review.
Cited by
-
Modifiable Pancreatic Ductal Adenocarcinoma (PDAC) Risk Factors.J Clin Med. 2023 Jun 27;12(13):4318. doi: 10.3390/jcm12134318. J Clin Med. 2023. PMID: 37445352 Free PMC article. Review.
-
miR-146a Inhibited Pancreatic Cancer Cell Proliferation by Targeting SOX7.J Healthc Eng. 2022 Feb 16;2022:2240605. doi: 10.1155/2022/2240605. eCollection 2022. J Healthc Eng. 2022. Retraction in: J Healthc Eng. 2023 Aug 9;2023:9870145. doi: 10.1155/2023/9870145. PMID: 35222878 Free PMC article. Retracted.
-
Incidence and risk factors of pancreatic cancer during 15 years follow-up in the Golestan Cohort Study in Iran.PLoS One. 2024 Jun 7;19(6):e0300736. doi: 10.1371/journal.pone.0300736. eCollection 2024. PLoS One. 2024. PMID: 38848337 Free PMC article.
-
A burden of proof study of the effects of exposure to high fasting plasma glucose on the risk of seven types of cancer.Sci Rep. 2025 Aug 7;15(1):28859. doi: 10.1038/s41598-025-13045-9. Sci Rep. 2025. PMID: 40775253 Free PMC article.
-
Targeting PI3K/AKT/mTOR Signaling Pathway in Pancreatic Cancer: From Molecular to Clinical Aspects.Int J Mol Sci. 2022 Sep 4;23(17):10132. doi: 10.3390/ijms231710132. Int J Mol Sci. 2022. PMID: 36077529 Free PMC article. Review.
References
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492 - PubMed
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30. doi:10.3322/caac.21332 - PubMed
-
- Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11–30. doi:10.3322/caac.21166 - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous